Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins

Future Microbiology

Volumn 5, Issue 8, 2010, Pages 1185-1201

  Wilson, Brenda A ^a   Ho, Mengfei ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

cysteine protease; cytotoxic necrotizing factor; deamidation; dermonecrotic toxin; GTPase; heterotrimeric G proteins; Pasteurella multocida toxin; signal transduction; transglutamination

Indexed keywords

BACTERIAL TOXIN; CYTOTOXIC NECROTIZING FACTOR 1; DEAMINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN CNF 2; PROTEIN CNF 3; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; BORDETELLA; CATALYSIS; DEAMINATION; ESCHERICHIA COLI; GLYCOSYLATION; PASTEURELLA MULTOCIDA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SKIN NECROSIS; YERSINIA;

BACTERIAL TOXINS; BORDETELLA; CYTOTOXINS; DEAMINATION; ESCHERICHIA COLI; GTP-BINDING PROTEINS; MODELS, BIOLOGICAL; PASTEURELLA MULTOCIDA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; YERSINIA;

BACTERIA (MICROORGANISMS); BORDETELLA; ESCHERICHIA COLI; PASTEURELLA MULTOCIDA; YERSINIA;

EID: 77955933830     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.91     Document Type: Review

References (162)

1. Dautin N, Karimova G, Ladant D: Bordetella pertussis adenylate cyclase toxin: a versatile screening tool. Toxicon 40(10), 1383-1387 (2002).
2. Fabbri A, Travaglione S, Falzano L, Fiorentini C: Bacterial protein toxins: current and potential clinical use. Curr. Med. Chem. 15(11), 1116-1125 (2008).
3. Kostrzewa RM, Segura-Aguilar J: Botulinum neurotoxin: evolution from poison, to research tool -onto medicinal therapeutic and future pharmaceutical panacea. Neurotox Res. 12(4), 275-290 (2007).
4. Lemonnier M, Landraud L, Lemichez E: Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol. Rev. 31(5), 515-534 (2007).
5. Mathew M, Verma RS: Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy. Cancer Sci. 100(8), 1359-1365 (2009).
6. Sandvig K, Van Deurs B: Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 12(11), 865-872 (2005).
7. Schiavo G, Van Der Goot FG: The bacterial toxin toolkit. Nat. Rev. Mol. Cell Biol. 2(7), 530-537 (2001).
8. Ui M, Katada T: Bacterial toxins as probes for receptor-G. coupling. Adv. Second MessengerPhosphoprotein Res. 24, 63-69 (1990).
9. Wilson BA, Ho M: Pasteurella multocida toxin as a tool for studying Gq signal transduction. Rev. Physiol. Biochem. Pharmacol. 152, 93-109 (2004).
10. Deng Q, Barbieri JT: Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu. Rev. Microbiol. 62, 271-288 (2008).
11. Jank T, Aktories K: Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16(5), 222-229 (2008).
12. Thelestam M, Frisan T: Cytolethal distending toxins. Rev. Physiol. Biochem. Pharmacol. 152, 111-133 (2004).
13. Jackson MP: Structure-function analyses of Shiga toxin and the Shiga-like toxins. Microb. Pathog. 8(4), 235-242 (1990).
14. Mukherjee S, Hao YH, Orth K: A newly discovered post-translational modification -the acetylation of serine and threonine residues. Trends Biochem. Sci. 32(5), 210-216 (2007).
15. Cornelis GR: Molecular and cell biology aspects of plague. Proc. Natl Acad. Sci. USA 97(16), 8778-8783 (2000).
16. Lebrun I, Marques-Porto R, Pereira AS, Pereira A, Perpetuo EA: Bacterial toxins: an overview on bacterial proteases and their action as virulence factors. Mini Rev. Med. Chem. 9(7), 820-828 (2009).
17. Satchell KJ: MARTX, multifunctional autoprocessing repeats-in-toxin toxins. Infect. Immun. 75(11), 5079-5084 (2007).
18. Fukui A, Horiguchi Y: Bordetella dermonecrotic toxin exerting toxicity through activation of the small GTPase Rho. J. Biochem. 136(4), 415-419 (2004).
19. Hoffmann C, Schmidt G: CNF and DNT. Rev. Physiol. Biochem. Pharmacol. 152, 49-63 (2004).
20. Munro P, Lemichez E: Bacterial toxins activating Rho GTPases. Curr. Top. Microbiol Immunol. 291, 177-190 (2005).
21. Orth JH, Preuss I, Fester I, Schlosser A, Wilson BA, Aktories K: Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. Proc. Natl Acad. Sci. USA 106(17), 7179-7184 (2009).
22. Neer EJ, Clapham DE: Roles of G protein subunits in transmembrane signalling. Nature 333(6169), 129-134 (1988).
23. Sprang SR: G proteins, effectors and GAPS: structure and mechanism. Curr. Opin. Struct. Biol. 7(6), 849-856 (1997).
24. Sprang SR: G protein mechanisms: insights from structural analysis. Annu. Rev. Biochem. 66, 639-678 (1997).
25. Stryer L, Bourne HR: G proteins: a family of signal transducers. Annu. Rev. Cell Biol. 2, 391-419 (1986).
26. Hall A: Rho GTPases and the actin cytoskeleton. Science 279(5350), 509-514 (1998).
27. Rens-Domiano S, Hamm HE: Structural and functional relationships of heterotrimeric G-proteins. FASEBJ. 9(11), 1059-1066 (1995).
28. Wilkie TM, Gilbert DJ, Olsen AS et al.: Evolution of the mammalian G protein a subunit multigene family. Nat. Genet. 1(2), 85-91 (1992).
29. Graziano MP, Freissmuth M, Gilman AG: Expression of Gs a in Escherichia coli. Purification and properties of two forms of the protein. J. Biol. Chem. 264(1), 409-418 (1989).
30. Ahmadian MR, Stege P, Scheffzek K, Wittinghofer A: Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat. Struct. Biol. 4(9), 686-689 (1997).
31. Mittal R, Ahmadian MR, Goody RS, Wittinghofer A: Formation of a transition-state analog of the Ras GTPase reaction by Ras-GDP, tetrafluoroaluminate, and GTPase-activating proteins. Science 273(5271), 115-117 (1996).
32. Rittinger K, Walker PA, Eccleston JF et al.: Crystal structure of a small G protein in complex with the GTPase-activating protein RhoGAP. Nature 388(6643), 693-697 (1997).
33. Rittinger K, Walker PA, Eccleston JF, Smerdon SJ, Gamblin SJ: Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 389(6652), 758-762 (1997).
34. Scheffzek K, Ahmadian MR, Kabsch W et al.: The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277(5324), 333-338 (1997).
35. Tesmer JJ, Berman DM, Gilman AG, Sprang SR: Structure of RGS4 bound to AlF4-activated G(ia1): stabilization of the transition state for GTP hydrolysis. Cell 89(2), 251-261 (1997).
36. Jorgensen R, Merrill AR, Andersen GR: The life and death of translation elongation factor 2. Biochem. Soc. Trans. 34(Pt 1), 1-6 (2006).
37. Parmeggiani A, Sander G: Properties and regulation of the GTPase activities of elongation factors Tu and G, and of initiation factor 2. Mol. Cell Biochem. 35(3), 129-158 (1981).
38. Rodnina MV, Fricke R, Kuhn L, Wintermeyer W: Codon-dependent conformational change of elongation factor Tu preceding GTP hydrolysis on the ribosome. EMBO J. 14(11), 2613-2619 (1995).
39. Rodnina MV, Pape T, Fricke R, Wintermeyer W: Elongation factor Tu, a GTPase triggered by codon recognition on the ribosome: mechanism and GTP consumption. Biochem. Cell Biol. 73(11-12), 1221-1227 (1995).
40. Rodnina MV, Savelsbergh A, Katunin VI, Wintermeyer W: Hydrolysis of GTP by elongation factor G drives tRNA movement on the ribosome. Nature 385(6611), 37-41 (1997).
41. Wilson BA, Collier RJ: Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism. Curr. Top. Microbiol. Immunol. 175, 27-41 (1992).
42. Jorgensen R, Yates SP, Teal DJ et al.: Crystal structure of ADP-ribosylated ribosomal translocase from Saccharomyces cerevisiae. J. Biol. Chem. 279(44), 45919-45925 (2004).
43. Nygard O, Nilsson L: Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes. J. Biol. Chem. 265(11), 6030-6034 (1990).
44. Pappenheimer AM Jr, Dunlop PC, Adolph KW, Bodley JW: Occurrence of diphthamide in archaebacteria. J. Bacteriol. 153(3), 1342-1347 (1983).
45. Casey PJ, Gilman AG: G protein involvement in receptor-effector coupling. J. Biol. Chem. 263(6), 2577-2580 (1988).
46. Gierschik P: ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin. Curr. Top. Microbiol. Immunol. 175, 69-96 (1992).
47. Kahn RA, Gilman AG: ADP-ribosylation of Gs promotes the dissociation of its a and p subunits. J. Biol. Chem. 259(10), 6235-6240 (1984).
48. Fields TA, Casey PJ: Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J. 321(Pt 3), 561-571 (1997).
49. Conklin BR, Bourne HR: Structural elements of G a subunits that interact with G p g, receptors, and effectors. Cell 73 (4), 631-641 (1993).
50. Sunyer T, Monastirsky B, Codina J, Birnbaumer L: Studies on nucleotide and receptor regulation of G, proteins: effects of pertussis toxin. Mol. Endocrinol. 3(7), 1115-1124 (1989).
51. Aktories K, Schmidt G, Just I: Rho GTPases as targets of bacterial protein toxins. Biol. Chem. 381(5-6), 421-426 (2000).
52. Van Aelst L, D'souza-Schorey C: Rho GTPases and signaling networks. Genes Dev. 11(18), 2295-2322 (1997).
53. Aktories K, Braun U, Rosener S, Just I, Hall A: The Rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem. Biophys. Res. Commun. 158(1), 209-213 (1989).
54. Just I, Mohr C, Schallehn G et al.: Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum. J. Biol. Chem. 267(15), 10274-10280 (1992).
55. Sugai M, Hashimoto K, Kikuchi A et al.: Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J. Biol. Chem. 267(4), 2600-2604 (1992).
56. Wilde C, Chhatwal GS, Schmalzing G, Aktories K, Just I: A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3. J. Biol. Chem. 276(12), 9537-9542 (2001).
57. Just I, Selzer J, Jung M, Van Damme J, Vandekerckhove J, Aktories K: Rho-ADP-ribosylating exoenzyme from Bacillus cereus. Purification, characterization, and identification of the NAD-binding site. Biochemistry 34(1), 334-340 (1995).
58. Sehr P, Joseph G, Genth H, Just I, Pick E, Aktories K: Glucosylation and ADP ribosylation of rho Proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry 37(15), 5296-5304 (1998).
59. Busch C, Aktories K: Microbial toxins and the glycosylation of Rho family GTPases. Curr. Opin. Struct. Biol. 10(5), 528-535 (2000).
60. Voth DE, Ballard JD: Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18(2), 247-263 (2005).
61. Chaves-Olarte E, Weidmann M, Eichel-Streiber C, Thelestam M: Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J. Clin. Invest. 100(7), 1734-1741 (1997).
62. Popoff MR, Chaves-Olarte E, Lemichez E et al.: Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J. Biol. Chem. 271(17), 10217-10224 (1996).
63. Shao F, Merritt PM, Bao Z, Innes RW, Dixon JE: A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 109(5), 575-588 (2002).
64. Buchwald G, Friebel A, Galan JE, Hardt WD, Wittinghofer A, Scheffzek K: Structural basis for the reversible activation of a rho protein by the bacterial toxin SopE. EMBO J. 21(13), 3286-3295 (2002).
65. Ohlson MB, Huang Z, Alto NM et al.: Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. Cell Host Microbe 4(5), 434-446 (2008).
66. Ohya K, Handa Y, Ogawa M, Suzuki M, Sasakawa C: IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation. J. Biol. Chem. 280(25), 24022-24034 (2005).
67. Arbeloa A, Bulgin RR, Mackenzie G et al.: Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens. Cell Microbiol. 10(7), 1429-1441 (2008).
68. Arbeloa A, Garnett J, Lillington J et al.: EspM2 is a RhoA guanine nucleotide exchange factor. Cell Microbiol. 12(5), 654-664 (2010).
69. Huang Z, Sutton SE, Wallenfang AJ et al.: Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat. Struct. Mol. Biol. 16(8), 853-860 (2009).
70. Bulgin RR, Arbeloa A, Chung JC, Frankel G: EspT triggers formation of lamellipodia and membrane ruffles through activation of Rac-1 and Cdc42. Cell Microbiol. 11(2), 217-229 (2009).
71. Bulgin R, Raymond B, Garnett JA et al.: Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect. Immun. 78(4), 1417-1425 (2010).
72. Alto NM, Shao F, Lazar CS et al.: Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124(1), 133-145 (2006).
73. Amor JC, Swails J, Zhu X et al.: The structure of RalF, an ADP-ribosylation factor guanine nucleotide exchange factor from Legionella pneumophila, reveals the presence of a cap over the active site. J. Biol. Chem. 280(2), 1392-1400 (2005).
74. Barbieri JT, Sun J: Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 152, 79-92 (2004).
75. Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT: The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J. Biol. Chem. 274(51), 36369-36372 (1999).
76. Wurtele M, Renault L, Barbieri JT, Wittinghofer A, Wolf E: Structure of the ExoS GTPase activating domain. FEBS Lett. 491(1-2), 26-29 (2001).
77. Fu Y, Galan JE: A Salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401(6750), 293-297 (1999).
78. Kaniga K, Uralil J, Bliska JB, Galan JE: A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 21(3), 633-641 (1996).
79. Black DS, Bliska JB: The RhoGap activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 37(3), 515-527 (2000).
80. Evdokimov AG, Tropea JE, Routzahn KM, Waugh DS: Crystal structure of the Yersinia pestis GTPase activator YopE. Protein Sci. 11(2), 401-408 (2002).
81. Coburn J, Dillon ST, Iglewski BH, Gill DM: Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin. Infect. Immun. 57(3), 996-998 (1989).
82. Coburn J, Wyatt RT, Iglewski BH, Gill DM: Several GTP-binding proteins, including p21c-h-Ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S. J. Biol. Chem. 264(15), 9004-9008 (1989).
83. Ganesan AK, Frank DW, Misra RP, Schmidt G, Barbieri JT: Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. J. Biol. Chem. 273(13), 7332-7337 (1998).
84. Ganesan AK, Vincent TS, Olson JC, Barbieri JT: Pseudomonas aeruginosa exoenzyme S disrupts Ras-mediated signal transduction by inhibiting guanine nucleotide exchange factor-catalyzed nucleotide exchange. J. Biol. Chem. 274(31), 21823-21829 (1999).
85. Sun J, Barbieri JT: Pseudomonas aeruginosa ExoT ADP-ribosylates ct10 regulator of kinase (Crk) proteins. J. Biol. Chem. 278(35), 32794-32800 (2003).
86. Navarro L, Koller A, Nordfelth R, Wolf-Watz H, Taylor S, Dixon JE: Identification of a molecular target for the Yersinia protein kinase A. Mol. Cell 26(4), 465-477 (2007).
87. Prehna G, Ivanov MI, Bliska JB, Stebbins CE: Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors. Cell 126(5), 869-880 (2006).
88. Ingmundson A, Delprato A, Lambright DG, Roy CR: Legionella pneumophila proteins that regulate Rab1 membrane cycling. Nature 450(7168), 365-369 (2007).
89. Machner MP, Isberg RR: A bifunctional bacterial protein links GDI displacement to Rab1 activation. Science 318(5852), 974-977
90. Zhu Y, Hu L, Zhou Y, Yao Q, Liu L, Shao F: Structural mechanism of host Rab1 activation by the bifunctional Legionella type IV effector SidM/DrrA. Proc. Natl Acad. Sci. USA 107(10), 4699-4704 (2010).
91. Sheahan Kl, Satchell KJ: Inactivation of small Rho GTPases by the multifunctional RTX toxin from Vibrio cholerae. Cell Microbiol. 9(5), 1324-1335 (2007).
92. Geissler B, Bonebrake A, Sheahan KL, Walker ME, Satchell KJ: Genetic determination of essential residues of the Vibrio cholerae actin cross-linking domain reveals functional similarity with glutamine synthetases. Mol. Microbiol. 73(5), 858-868 (2009).
93. Kudryashov DS, Cordero CL, Reisler E, Satchell KJ: Characterization of the enzymatic activity of the actin cross-linking domain from the Vibrio cholerae MARTX Vc toxin. J. Biol. Chem. 283(1), 445-452
94. Kudryashov DS, Durer ZA, Ytterberg AJ et al.: Connecting actin monomers by iso-peptide bond is a toxicity mechanism of the Vibrio cholerae MARTX toxin. Proc. Natl Acad. Sci. USA 105(47), 18537-18542 (2008).
95. Prochazkova K, Satchell KJ: Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional autoprocessing RTx toxin. J. Biol. Chem. 283(35), 23656-23664 (2008).
96. Prochazkova K, Shuvalova LA, Minasov G, Voburka Z, Anderson WF, Satchell KJ: Structural and molecular mechanism for autoprocessing of MARTX toxin of Vibrio cholerae at multiple sites. J. Biol. Chem. 284(39), 26557-26568 (2009).
97. Shen A, Lupardus PJ, Albrow VE et al.: Mechanistic and structural insights into the proteolytic activation of Vibrio cholerae MARTX toxin. Nat. Chem. Biol. 5(7), 469-478 (2009).
98. Flatau G, Landraud L, Boquet P, Bruzzone M, Munro P: Deamidation of RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain. Biochem. Biophys. Res. Commun. 267(2), 588-592 (2000).
99. Flatau G, Lemichez E, Gauthier M et al.: Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387(6634), 729-733 (1997).
100. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K: Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387(6634), 725-729 (1997).
101. Lerm M, Schmidt G, Goehring UM, Schirmer J, Aktories K: Identification of the region of Rho involved in substrate recognition by Escherichia coli cytotoxic necrotizing factor 1 (CNF1). J. Biol. Chem. 274(41), 28999-29004 (1999).
102. Hoffmann C, Pop M, Leemhuis J, Schirmer J, Aktories K, Schmidt G: The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFy) selectively activates RhoA. J. Biol. Chem. 279(16), 16026-16032 (2004).
103. Schmidt G, Selzer J, Lerm M, Aktories K: The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J. Biol. Chem. 273(22), 13 669-13 674 (1998).
104. Horiguchi Y: Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases. Toxicon 39(11), 1619-1627 (2001).
105. Masuda M, Minami M, Shime H, Matsuzawa T, Horiguchi Y: In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin. Infect. Immun. 70(2), 998-1001 (2002).
106. Schmidt G, Goehring UM, Schirmer J, Lerm M, Aktories K: Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for Rho GTPases. J. Biol. Chem. 274(45), 31875-31881 (1999).
107. Masuda M, Betancourt L, Matsuzawa T et al.: Activation of Rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin. EMBO J. 19(4), 521-530 (2000).
108. Schmidt G, Goehring UM, Schirmer J et al.: Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin. Infect. Immun. 69(12), 7663-7670 (2001).
109. Buetow L, Flatau G, Chiu K, Boquet P, Ghosh P: Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat. Struct. Biol. 8(7), 584-588 (2001).
110. Jank T, Pack U, Giesemann T, Schmidt G, Aktories K: Exchange of a single amino acid switches the substrate properties of RhoA and RhoD toward glucosylating and transglutaminating toxins. J. Biol. Chem. 281(28), 19527-19535 (2006).
111. Rhee SG, Choi KD: Regulation of inositol phospholipid-specific phospholipase C isozymes. J. Biol. Chem. 267(18), 12393-12396 (1992).
112. Sternweis PC, Smrcka AV: Regulation of phospholipase C by G proteins. Trends Biochem. Sci. 17(12), 502-506 (1992).
113. Strathmann M, Simon MI: G protein diversity: a distinct class of a subunits is present in vertebrates and invertebrates. Proc. Natl Acad. Sci. USA 87(23), 9113-9117 (1990).
114. Wilson BA, Zhu X, Ho M, Lu L: Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q) a-coupled phospholipase C-p1. J. Biol. Chem. 272(2), 1268-1275
115. Zywietz A, Gohla A, Schmelz M, Schultz G, Offermanns S: Pleiotropic effects of Pasteurella multocida toxin are mediated by Gq-dependent and -independent mechanisms. Involvement of Gq but not G11. J. Biol. Chem. 276(6), 3840-3845 (2001).
116. Aminova LR, Wilson BA: Calcineurin-independent inhibition of 3T3-L1 adipogenesis by Pasteurella multocida toxin: suppression of notch1, stabilization of p-catenin and pre-adipocyte factor 1. Cell Microbiol. 9(10), 2485-2496
117. Luo S, Ho M, Wilson BA: Application of intact cell-based NFAT-p-lactamase reporter assay for Pasteurella multocida toxin-mediated activation of calcium signaling pathway. Toxicon 51(4), 597-605
118. Mullan PB, Lax AJ: Pasteurella multocida toxin stimulates bone resorption by osteoclasts via interaction with osteoblasts. Calcif. Tissue Int. 63(4), 340-345
119. Murphy AC, Rozengurt E: Pasteurella multocida toxin selectively facilitates phosphatidylinositol 4,5-bisphosphate hydrolysis by bombesin, vasopressin, and endothelin. Requirement for a functional G protein. J. Biol. Chem. 267(35), 25296-25303 (1992).
120. + in Swiss 3T3 cells. J. Biol. Chem. 266(8), 4840-4847 (1991).
121. Staddon JM, Chanter N, Lax AJ, Higgins T E , Rozeng urt E : Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells. J. Biol. Chem. 265(20), 11841-11848 (1990).
122. Orth JH, Aktories K, Kubatzky KF: Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin. J. Biol. Chem. 282(5), 3050-3057 (2007).
123. Rozengurt E, Higgins T, Chanter N, Lax AJ, Staddon JM: Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc. Natl Acad. Sci. USA 87(1), 123-127 (1990).
124. Sabri A, Wilson BA, Steinberg SF: Dual actions of the Ga(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ. Res. 90(8), 850-857 (2002).
125. Seo B, Choy EW, Maudsley S, Miller WE, Wilson BA, Luttrell LM: Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G(q/11)-dependent transactivation of the epidermal growth factor receptor. J. Biol. Chem. 275(3), 2239-2245 (2000).
126. Wilson BA, Aminova LR, Ponferrada VG, Ho M: Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin. Infect. Immun. 68(8), 4531-4538 (2000).
127. Aepfelbacher M, Essler M: Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators: a role for Rho/Rho kinase. Cell Microbiol. 3(10), 649-658 (2001).
128. Essler M, Hermann K, Amano M et al.: Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase. J. Immunol. 161(10), 5640-5646 (1998).
129. Lacerda HM, Lax AJ, Rozengurt E: Pasteurella multocida toxin, a potent intracellularly acting mitogen, induces p125fak and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in swiss 3T3 cells. J. Biol. Chem. 271(1), 439-445 (1996).
130. Ohnishi T, Horiguchi Y, Masuda M, Sugimoto N, Matsuda M: Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms. J. Vet. Med. Sci. 60(3), 301-305 (1998).
131. Sagi SA, Seasholtz TM, Kobiashvili M, Wilson BA, Toksoz D, Brown JH: Physical and functional interactions of Gaq with Rho and its exchange factors. J. Biol. Chem. 276(18), 15445-15452 (2001).
132. Thomas W, Pullinger GD, Lax AJ, Rozengurt E: Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association. Infect. Immun. 69(9), 5931-5935 (2001).
133. Orth JH, Lang S, Preuss I, Milligan G, Aktories K: Action of Pasteurella multocida toxin on Ga (q) is persistent and independent of interaction with G-protein-coupled receptors. Cell Signal 19(10), 2174-2182 (2007).
134. Orth JH, Fester I, Preuss I, Agnoletto L, Wilson BA, Aktories K: Activation of Ga (i) and subsequent uncoupling of receptor-Ga(i) signaling by Pasteurella multocida toxin. J. Biol. Chem. 283(34), 23288-23294 (2008).
135. Preuss I, Kurig B, Nurnberg B, Orth JH, Aktories K: Pasteurella multocida toxin activates Gpg dimers of heterotrimeric G proteins. Cell Signal. 21(4), 551-558 (2009).
136. Katada T, Oinuma M, Ui M: Two guanine nucleotide-binding proteins in rat brain serving as the specific substrate of islet-activating protein, pertussis toxin. Interaction of the a-subunits with p g-subunits in development of their biological activities. J. Biol. Chem. 261(18), 8182-8191 (1986).
137. Orth JH, Lang S, Taniguchi M, Aktories K: Pasteurella multocida toxin-induced activation of RhoA is mediated via two families of G {a} proteins, G{a}q and G{a}12/13. J. Biol. Chem. 280(44), 36701-36707 (2005).
138. Buhl AM, Johnson NL, Dhanasekaran N, Johnson GL: Ga 12 and G a 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J. Biol. Chem. 270(42), 24631-24634 (1995).
139. Goulimari P, Knieling H, Engel U, Grosse R: Larg and Mdia1 link Ga12/13 to cell polarity and microtubule dynamics. Mol. Biol. Cell 19(1), 30-40 (2008).
140. Jin S, Exton JH: Activation of RhoA by association of Ga(13) with DBL. Biochem. Biophys. Res. Commun. 277(3), 718-721 (2000).
141. Tanabe S, Kreutz B, Suzuki N, Kozasa T: Regulation of RGS-RhoGEFs by Ga12 and Ga13 proteins. Methods Enzymol. 390, 285-294 (2004).
142. Yamaguchi Y, Katoh H, Negishi M: N-terminal short sequences of a subunits of the G12 family determine selective coupling to receptors. J. Biol. Chem. 278(17), 14936-14939 (2003).
143. Orth JH, Lang S, Aktories K: Action of Pasteurella multocida toxin depends on the helical domain of Gaq. J. Biol. Chem. 279(33), 34150-34155 (2004).
144. Kashimoto T, Katahira J, Cornejo WR et al.: Identification of functional domains of Bordetella dermonecrotizing toxin. Infect. Immun. 67(8), 3727-3732 (1999).
145. Lemichez E, Flatau G, Bruzzone M, Boquet P, Gauthier M: Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. Mol. Microbiol. 24(5), 1061-1070 (1997).
146. Pullinger GD, Sowdhamini R, Lax AJ: Localization of functional domains of the mitogenic toxin of Pasteurella multocida. Infect. Immun. 69(12), 7839-7850 (2001).
147. Aminova LR, Luo S, Bannai Y, Ho M, Wilson BA: The C3 domain of Pasteurella multocida toxin is the minimal domain responsible for activation of Gq-dependent calcium and mitogenic signaling. Protein Sci. 17(5), 945-949 (2008).
148. Kitadokoro K, Kamitani S, Miyazawa M et al.: Crystal structures reveal a thiol protease-like catalytic triad in the C-terminal region of Pasteurella multocida toxin. Proc. Natl Acad. Sci. USA 104(12), 5139-5144 (2007).
149. Sugai M, Hatazaki K, Mogami A et al.: Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a Gln residue in the conserved G-3 domain of the Rho family and preferentially inhibits the GTPase activity of RhoA and Rac1. Infect. Immun. 67(12), 6550-6557 (1999).
150. Kamitani S, Kitadokoro K, Miyazawa M et al.: Characterization of the membrane-targeting C1 domain in Pasteurella multocida toxin. J. Biol. Chem. DOI: 10.1074/jbc.M110.102285 (2010) (Epub ahead of print).
151. Busch C, Orth J, Djouder N, Aktories K: Biological activity of a C-terminal fragment of Pasteurella multocida toxin. Infect. Immun. 69(6), 3628-3634 (2001).
152. Orth JH, Blocker D, Aktories K: His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin. Biochemistry 42(17), 4971-4977 (2003).
153. Ginalski K, Kinch L, Rychlewski L, Grishin NV: BTLCP proteins: a novel family of bacterial transglutaminase-like cysteine proteinases. Trends Biochem. Sci. 29(8), 392-395 (2004).
154. Yee VC, Pedersen LC, Bishop PD, Stenkamp RE, Teller DC: Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. Thromb. Res. 78(5), 389-397 (1995).
155. Noguchi K, Ishikawa K, Yokoyama K, Ohtsuka T, Nio N, Suzuki E: Crystal structure of red sea bream transglutaminase. J. Biol. Chem. 276(15), 12055-12059 (2001).
156. Yamaguchi S, Jeenes DJ, Archer DB: Protein-glutaminase from Chryseobacterium proteolyticum, an enzyme that deamidates glutaminyl residues in proteins. Purification, characterization and gene cloning. Eur. J. Biochem. 268(5), 1410-1421 (2001).
157. Sinclair JC, Sandy J, Delgoda R, Sim E, Noble ME: Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat. Struct. Biol. 7(7), 560-564 (2000).
158. Kashiwagi T, Yokoyama K, Ishikawa K et al.: Crystal structure of microbial transglutaminase from Streptoverticillium mobaraense. J. Biol. Chem. 277(46), 44252-44260 (2002).
159. Yokoyama K, Nio N, Kikuchi Y: Properties and applications of microbial transglutaminase. Appl. Microbiol. Biotechnol. 64(4), 447-454 (2004).
160. Chao X, Muff TJ, Park SY et al.: A receptor-modifying deamidase in complex with a signaling phosphatase reveals reciprocal regulation. Cell 124(3), 561-571 (2006).
161. Kim Y, Maltseva N, Dementieva I, Collart F, Holzle D, Joachimiak A: Crystal structure of hypothetical protein YfiH from Shigella flexneri at 2 A resolution. Proteins 63(4), 1097-1101 (2006).
162. Lax AJ: Opinion: bacterial toxins and cancer -a case to answer? Nat. Rev. Microbiol. 3 (4), 343-349 (2005).